INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY

被引：0

作者：

Roeth, A. ^{[1
]}

Barcellini, W. ^{[2
]}

D'Sa, S. ^{[3
]}

Miyakawa, Y. ^{[4
]}

Broome, C. M. ^{[5
]}

Michel, M. ^{[6
]}

Kuter, D. J. ^{[7
]}

Jilma, B. ^{[8
]}

Tvedt, T. H. Anderson ^{[9
]}

Lin, S. ^{[10
]}

Jiang, X. ^{[10
]}

Reuter, C.

Hobbs, W. ^{[10
]}

Berentsen, S. ^{[11
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, West German Canc Ctr, Essen, Germany

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England

[4] Saitama Med Univ Hosp, Ctr Thrombosis & Hemostasis, Saitama, Japan

[5] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA

[6] UPEC, Henri Mondor Univ Hosp, Assistance Publ Hop Paris, Creteil, France

[7] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA

[8] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[9] Haukeland Hosp, Sect Hematol, Dept Med, Bergen, Norway

[10] Sanofi, Waltham, MA USA

[11] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway

来源：

HAEMATOLOGICA | 2020年 / 105卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C028

引用

页码：S38 / S38

页数：1

共 50 条

[31] Combined Safety Data for Sutimlimab in Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cardinal and Cadenza Studies
Broome, Catherine M.
Barcellini, Wilma
Ueda, Yasutaka
Khan, Umer
Patel, Reena
Wardecki, Marek
Kralova, Katarina
Srivastava, Shruti
Roeth, Alexander
[J]. BLOOD, 2023, 142
[32] Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
D'Sa, Shirley
Vos, Josephine M. I.
Barcellini, Wilma
Wardecki, Marek
Perrin, Laurent
Barker, Graham
Zilberstein, Moshe
Storek, Michael
Chow, Timothy
Roeth, Alexander
[J]. BLOOD, 2024, 143 (08) : 713 - 720
[33] Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition
Alashkar, Ferras
Herich-Terhuerne, Doerte
Preising, Nicole
Duehrsen, Ulrich
Ulrich, Vogel
Roeth, Alexander
[J]. BLOOD, 2018, 132
[34] Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibition
Alashkar, Ferras
Vance, Colin
Herich-Terhuerne, Dorte
Turki, Amin T.
Schmitz, Christine
Bommer, Martin
Huettmann, Andreas
Duehrsen, Ulrich
Vogel, Ulrich
Roeth, Alexander
[J]. VACCINE, 2019, 37 (44) : 6682 - 6687
[35] Inhibition of Complement Cis By Suti limab in Patients h Cold Agglutinin Disease (CAD): Efficacy and Safety Results om the Rando ized, Placebo-Controlled Phase 3 CADENZA Study
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-Ichi
Vos, Josephine M. I.
Storek, Michael
Wong, Nancy
Patel, Parija
Schaible, Braydon
Jiang, Xiaoyu
Vagge, Deepthi
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
[J]. BLOOD, 2021, 138
[36] THE ANTI C1S COMPLEMENT ANTIBODY TNT009 INDUCES RAPID COMPLETE REMISSIONS OF ANAEMIA IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE
Jaeger, U.
Gilbert, J. C.
Panicker, S.
Parry, G. C.
Fillitz, M.
Schenk, T.
Sillaber, C.
Bartko, J.
Jilma, B.
[J]. HAEMATOLOGICA, 2016, 101 : 341 - 341
[37] Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study
Roeth, Alexander
Broome, Catherine M.
Barcellini, Wilma
Jilma, Bernd
Hill, Quentin A.
Cella, David
Tvedt, Tor Henrik Anderson
Yamaguchi, Masaki
Lee, Michelle
Shafer, Frank
Wardecki, Marek
Jiang, Xiaoyu
Patel, Parija
Joly, Florence
Weitz, Ilene C.
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (03) : 280 - 288
[38] Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial
Gelbenegger, Georg
Jaeger, Ulrich
Fillitz, Michael
D'Sa, Shirley
Cartwright, Ronwyn
Shafer, Frank
Wardecki, Marek
Wang, Jennifer
Schoergenhofer, Christian
Jilma, Bernd
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : E59 - E62
[39] C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro
Nikitin, Pavel A.
Rose, Eileen L.
Byun, Tony S.
Parry, Graham C.
Panicker, Sandip
[J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (04): : 1200 - 1209
[40] Efficacy of Sutimlimab in Improving FACIT-Fatigue Scores in Patients with Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cadenza (Part A) Study
Roeth, Alexander
Weitz, Ilene
Ueda, Yasutaka
Bozzi, Sylvie
Patel, Reena
Karaouni, Alia
Yoo, Ronnie
Cella, David
Wang, Jennifer
[J]. BLOOD, 2023, 142

← 1 2 3 4 5 →